Your browser doesn't support javascript.
loading
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
Bruce, Ian N; Furie, Richard A; Morand, Eric F; Manzi, Susan; Tanaka, Yoshiya; Kalunian, Kenneth C; Merrill, Joan T; Puzio, Patricia; Maho, Emmanuelle; Kleoudis, Christi; Albulescu, Marius; Hultquist, Micki; Tummala, Raj.
  • Bruce IN; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal & Dermatological Sciences, The University of Manchester, Manchester, UK.
  • Furie RA; NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Morand EF; Division of Rheumatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.
  • Manzi S; Center for Inflammatory Disease, Monash University, Melbourne, Victoria, Australia.
  • Tanaka Y; Department of Medicine, Lupus Center of Excellence, Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Kalunian KC; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Merrill JT; Division of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, California, USA.
  • Puzio P; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Maho E; BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA.
  • Kleoudis C; BioPharmaceuticals R&D, AstraZeneca R&D, Cambridge, UK.
  • Albulescu M; BioPharmaceuticals R&D, AstraZeneca US, Durham, North Carolina, USA.
  • Hultquist M; BioPharmaceuticals R&D, AstraZeneca R&D, Cambridge, UK.
  • Tummala R; BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA.
Ann Rheum Dis ; 81(7): 962-969, 2022 07.
Article en En | MEDLINE | ID: mdl-35580976
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucocorticoides / Lupus Eritematoso Sistémico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucocorticoides / Lupus Eritematoso Sistémico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article